These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 26544809)

  • 1. HIV Infection Is Associated With Poor Outcomes for Patients With Anal Cancer in the Highly Active Antiretroviral Therapy Era.
    Grew D; Bitterman D; Leichman CG; Leichman L; Sanfilippo N; Moore HG; Du K
    Dis Colon Rectum; 2015 Dec; 58(12):1130-6. PubMed ID: 26544809
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High IDO1 Expression Is Associated with Poor Outcome in Patients with Anal Cancer Treated with Definitive Chemoradiotherapy.
    Mitra D; Horick NK; Brackett DG; Mouw KW; Hornick JL; Ferrone S; Hong TS; Mamon H; Clark JW; Parikh AR; Allen JN; Ryan DP; Ting DT; Deshpande V; Wo JY
    Oncologist; 2019 Jun; 24(6):e275-e283. PubMed ID: 30755500
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence and epidemiology of anal cancer in the multicenter AIDS cohort study.
    D'Souza G; Wiley DJ; Li X; Chmiel JS; Margolick JB; Cranston RD; Jacobson LP
    J Acquir Immune Defic Syndr; 2008 Aug; 48(4):491-9. PubMed ID: 18614927
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factors Impacting Differential Outcomes in the Definitive Radiation Treatment of Anal Cancer Between HIV-Positive and HIV-Negative Patients.
    Susko M; Wang CJ; Lazar AA; Kim S; Laffan A; Feng M; Ko A; Venook AP; Atreya CE; Van Loon K; Anwar M
    Oncologist; 2020 Sep; 25(9):772-779. PubMed ID: 32390297
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systematic review of outcome measures following chemoradiotherapy for the treatment of anal cancer (CORMAC).
    Fish R; Sanders C; Ryan N; der Veer SV; Renehan AG; Williamson PR
    Colorectal Dis; 2018 May; 20(5):371-382. PubMed ID: 29566456
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and Toxicity of (Chemo)Radiation Therapy in HIV+ Patients with Squamous Cell Anal Cancer, a Subgroup Analysis of the National Multicenter Cohort FFCD-ANABASE.
    Evin C; Quéro L; Le Malicot K; Blanchet-Deverly S; Evesque L; Buchalet C; Lemanski C; Hamed NB; Rivin Del Campo E; Bauwens L; Pommier P; Lièvre A; Gouriou C; Tougeron D; Macé V; Sergent G; Diaz O; Zucman D; Mornex F; Locher C; De la Rochefordière A; Vendrely V; Huguet F
    Int J Radiat Oncol Biol Phys; 2024 Jun; ():. PubMed ID: 38912999
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of non-metastatic anal cancer in the elderly: ancillary study of the French multicenter prospective cohort FFCD-ANABASE.
    Gouriou C; Lemanski C; Pommier P; Le Malicot K; Saint A; Rivin Del Campo E; Evin C; Quero L; Regnault P; Baba-Hamed N; Ronchin P; Crehange G; Tougeron D; Menager-Tabourel E; Diaz O; Hummelsberger M; de la Rocherfordiere A; Drouet F; Vendrely V; Lièvre A
    Br J Cancer; 2024 Mar; 130(5):769-776. PubMed ID: 38184691
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SEOM clinical guidelines for the treatment of anal cancer.
    Maurel J; Fernández-Martos C; Feliu J; Isla D
    Clin Transl Oncol; 2011 Aug; 13(8):525-7. PubMed ID: 21821485
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Encephalitis in HIV-infected adults in the antiretroviral therapy era.
    Reimer-Mcatee M; Ramirez D; Mcatee C; Granillo A; Hasbun R
    J Neurol; 2023 Aug; 270(8):3914-3933. PubMed ID: 37115358
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Asymptomatic anal sexually transmitted infections in HIV-positive men attending anal cancer screening.
    Fuchs W; Kreuter A; Hellmich M; Potthoff A; Swoboda J; Brockmeyer NH; Wieland U
    Br J Dermatol; 2016 Apr; 174(4):831-8. PubMed ID: 26577338
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Constructing the cascade of HIV care: methods for measurement.
    Haber N; Pillay D; Porter K; Bärnighausen T
    Curr Opin HIV AIDS; 2016 Jan; 11(1):102-8. PubMed ID: 26545266
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incidence, Duration, Persistence, and Factors Associated With High-risk Anal Human Papillomavirus Persistence Among HIV-negative Men Who Have Sex With Men: A Multinational Study.
    Nyitray AG; Carvalho da Silva RJ; Chang M; Baggio ML; Ingles DJ; Abrahamsen M; Papenfuss M; Lin HY; Salmerón J; Quiterio M; Lazcano-Ponce E; Villa LL; Giuliano AR
    Clin Infect Dis; 2016 Jun; 62(11):1367-1374. PubMed ID: 26962079
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preexposure Prophylaxis for HIV Infection Integrated With Municipal- and Community-Based Sexual Health Services.
    Liu AY; Cohen SE; Vittinghoff E; Anderson PL; Doblecki-Lewis S; Bacon O; Chege W; Postle BS; Matheson T; Amico KR; Liegler T; Rawlings MK; Trainor N; Blue RW; Estrada Y; Coleman ME; Cardenas G; Feaster DJ; Grant R; Philip SS; Elion R; Buchbinder S; Kolber MA
    JAMA Intern Med; 2016 Jan; 176(1):75-84. PubMed ID: 26571482
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systematic review of guidelines for the assessment and management of high-grade anal intraepithelial neoplasia (AIN II/III).
    Alam NN; White DA; Narang SK; Daniels IR; Smart NJ
    Colorectal Dis; 2016 Feb; 18(2):135-46. PubMed ID: 26559167
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Experiences with food insecurity and risky sex among low-income people living with HIV/AIDS in a resource-rich setting.
    Whittle HJ; Palar K; Napoles T; Hufstedler LL; Ching I; Hecht FM; Frongillo EA; Weiser SD
    J Int AIDS Soc; 2015; 18(1):20293. PubMed ID: 26546789
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinicopathological Characteristics and Outcomes of Anal Squamous Cell Carcinoma Patients With and Without HIV Infection in Sub-Saharan Africa.
    Mduma E; Dharsee N; Samwel K; Mwita CJ; Lidenge SJ
    JCO Glob Oncol; 2023 May; 9():e2200394. PubMed ID: 37216622
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic Factors of Long-Term Outcomes after Primary Chemo-Radiotherapy in Non-Metastatic Anal Squamous Cell Carcinoma: An International Bicentric Cohort.
    Iseas S; Prost D; Bouchereau S; Golubicki M; Robbio J; Oviedo A; Coraglio M; Kujaruk M; Méndez G; Carballido M; Roca E; Gros L; De Parades V; Baba-Hamed N; Adam J; Abba MC; Raymond E
    Biomedicines; 2023 Mar; 11(3):. PubMed ID: 36979770
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biomarkers in Anal Cancer: Current Status in Diagnosis, Disease Progression and Therapeutic Strategies.
    Mathias-Machado MC; Peixoto RD; Moniz CMV; Jácome AA
    Biomedicines; 2022 Aug; 10(8):. PubMed ID: 36009576
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Roles of the Virome in Cancer.
    Broecker F; Moelling K
    Microorganisms; 2021 Dec; 9(12):. PubMed ID: 34946139
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Prospective Cohort Study of Biomarkers in Squamous Cell Carcinoma of the Anal Canal (SCCAC) and their Influence on Treatment Outcomes.
    Moniz CMV; Riechelmann RP; Oliveira SCR; Bariani GM; Rivelli TG; Ortega C; Pereira AAL; Meireles SI; Franco R; Chen A; Bonadio RC; Nahas C; Sabbaga J; Coudry RA; Braghiroli MI; Hoff PM
    J Cancer; 2021; 12(23):7018-7025. PubMed ID: 34729104
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.